Announced
Completed
Financials
Tags
Belgium
biomanufacturing
Biotechnology
Friendly
Acquisition
Cross Border
Majority
Private
Completed
Single Bidder
Synopsis
Donaldson, a provider of innovative filtration products and solutions, completed the acquisition of Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable advanced therapies and vaccine production, from Gamma Biosciences, a life sciences platform created by KKR, €136m. "We are delighted that UT will join Donaldson as it expands its presence in biomanufacturing, leveraging its legacy of filtration technology leadership. UT has developed a best-in-class platform for efficient manufacturing of gene therapies and vaccines and will be well positioned as part of the larger Donaldson organization to support the market going forward," Matt Gunnison, Gamma Biosciences CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.